TIVIC HEALTH SYSTEMS INC (TIVC) Stock Overview
USA - NASDAQ:TIVC - US8887053085 - Common Stock
TIVC Key Statistics, Chart & Performance
The current stock price of TIVC is 2.84 USD. In the past month the price decreased by -5.35%. In the past year, price decreased by -46.3%.
TIVC Latest News, Press Relases and Analysis
TIVC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.37 | 220.33B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.79 | 196.89B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.45 | 150.61B | ||
| SYK | STRYKER CORP | 29.64 | 145.63B | ||
| MDT | MEDTRONIC PLC | 16.93 | 120.11B | ||
| BDX | BECTON DICKINSON AND CO | 13.06 | 53.41B | ||
| IDXX | IDEXX LABORATORIES INC | 53.56 | 51.46B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.78 | 44.93B | ||
| RMD | RESMED INC | 27.44 | 38.24B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.7 | 35.53B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.3 | 27.82B | ||
| DXCM | DEXCOM INC | 41.93 | 27.95B |
Related stock screener links
About TIVC
Company Profile
Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company is headquartered in Fremont, California and currently employs 7 full-time employees. The company went IPO on 2021-11-11. The company harnesses the power of the immune and autonomic nervous systems to fight disease and restore health. The company takes a multi-pronged approach to treating diseases caused by immune dysregulation and dysautonomia. The complement of bioelectronic and biologic medicines allows it to target disorders and disease via both neural pathways and molecular approaches. Its commercial product, ClearUP, is clinically proven to treat sinus pain and pressure. ClearUP is available through online retailers and commercial distributors. The company also has worldwide exclusive license rights to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimod for the treatment of acute radiation syndrome (ARS). In addition, it has an exclusive option to license five additional indications and clinical use cases for Entolimod and its derivative, Entalasta.
Company Info
TIVIC HEALTH SYSTEMS INC
47685 Lakeview Blvd
Fremont CALIFORNIA US
Employees: 7
Phone: 18882766888
TIVIC HEALTH SYSTEMS INC / TIVC FAQ
What does TIVIC HEALTH SYSTEMS INC do?
Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company is headquartered in Fremont, California and currently employs 7 full-time employees. The company went IPO on 2021-11-11. The company harnesses the power of the immune and autonomic nervous systems to fight disease and restore health. The company takes a multi-pronged approach to treating diseases caused by immune dysregulation and dysautonomia. The complement of bioelectronic and biologic medicines allows it to target disorders and disease via both neural pathways and molecular approaches. Its commercial product, ClearUP, is clinically proven to treat sinus pain and pressure. ClearUP is available through online retailers and commercial distributors. The company also has worldwide exclusive license rights to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimod for the treatment of acute radiation syndrome (ARS). In addition, it has an exclusive option to license five additional indications and clinical use cases for Entolimod and its derivative, Entalasta.
What is the stock price of TIVIC HEALTH SYSTEMS INC today?
The current stock price of TIVC is 2.84 USD. The price increased by 0.35% in the last trading session.
Does TIVC stock pay dividends?
TIVC does not pay a dividend.
What is the ChartMill technical and fundamental rating of TIVC stock?
TIVC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Is TIVIC HEALTH SYSTEMS INC (TIVC) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TIVC.
Can you provide the short interest for TIVC stock?
The outstanding short interest for TIVIC HEALTH SYSTEMS INC (TIVC) is 5.88% of its float.
TIVC Technical Analysis
TIVC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TIVC. While TIVC seems to be doing ok healthwise, there are quite some concerns on its profitability.
TIVC Financial Highlights
Over the last trailing twelve months TIVC reported a non-GAAP Earnings per Share(EPS) of -11.84. The EPS increased by 88.87% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -140.66% | ||
| ROE | -171.98% | ||
| Debt/Equity | 0 |